Orthovita To Double Sales Force For Vitoss Foam, Endoskeleton TA
This article was originally published in The Gray Sheet
Executive Summary
Orthovita will debut various iterations of its Vitoss Scaffold Foam bone graft material later this year, following 510(k) clearance of the platform technology